Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Clinical, Cosmetic and Investigational Dermatology|January 6, 2016
Prevalence of acute and chronic viral seropositivity and characteristics of disease in patients with psoriatic arthritis treated with cyclosporine: a post hoc analysis from a sex point of view on the observational study of infectious events in psoriasis complicated by active psoriatic arthritisDelia Colombo, Sergio Chimenti, Paolo Antonio Grossi, et al.
The Journal of Rheumatology|December 17, 2014
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter studyEnnio Lubrano, Fabio Massimo Perrotta, Antonio Marchesoni, et al.
Rheumatology and Therapy|February 17, 2020
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life StudyEnnio Lubrano, Fabio Massimo Perrotta, Maria Manara, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|February 4, 2016
Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY StudyDelia Colombo, Sergio Chimenti, Paolo A Grossi, et al.
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issuesSalvatore D'Angelo, Carlo Palazzi, Fabrizio Cantini, et al.
Biomed Research International|August 12, 2014
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen RegistryMatteo Filippini, Chiara Bazzani, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|February 8, 2024
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trialsFabrizio Cantini, Antonio Marchesoni, Lucia Novelli, et al.
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthropathies. Part I: current evidence of efficacyCarlo Palazzi, Salvatore D'Angelo, Fabrizio Cantini, et al.
Journal of Clinical Medicine|June 24, 2022
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR StudySalvatore D'Angelo, Carlo Salvarani, Francesca Marando, et al.
The Journal of Rheumatology|June 3, 2016
Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective StudyEnnio Lubrano, Fabio Massimo Perrotta, Maria Manara, et al.
Pageof 11